
Two recent interesting settlements at Massachusetts General Hospital (MGH), both involving technology. The first case involved a medication...
Two recent interesting settlements at Massachusetts General Hospital (MGH), both involving technology. The first case involved a medication...
On the 1BoringOldMan blog, semi-anonymous blogger Mickey has been dissecting in detail the infamous Study 329 that GlaxoSmithKline used to p...
Here are a few reasonable questions I decided to elevate as a post of its own. In the face of the discovery of industry influence over comme...
Note: Also see the followup Sept. 5, 2012 post " Was EPIC successful in watering down the Meaningful Use Stage 2 Final Rule? " at ...
A change in the leadership of one of the biggest health care organizations reveals a little more about how such leadership has become our ne...
Healthcare IT " glitches " as reported on this blog should make any clinician - and patient - wary of the technology in its presen...
In my post yesterday " The Scientific Justification for Meaningul Use, Stage 2 " I wrote: There's no truly robust evidence of ...